Get the Stockscreener App
29.65
4.42%
-1.37
After Hours:
29.31
-0.34
-1.15%
Eton Pharmaceuticals Inc stock is traded at $29.65, with a volume of 280.46K.
It is down -4.42% in the last 24 hours and up +12.33% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$31.02
Open:
$30.93
24h Volume:
280.46K
Relative Volume:
0.72
Market Cap:
$811.22M
Revenue:
$79.95M
Net Income/Loss:
$-4.60M
P/E Ratio:
-165.92
EPS:
-0.1787
Net Cash Flow:
$10.19M
1W Performance:
+2.60%
1M Performance:
+12.33%
6M Performance:
+75.44%
1Y Performance:
+71.09%
1-Day Range:
$29.29
$30.93
1-Week Range:
$28.93
$32.31
52-Week Range:
$13.09
$32.31
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
29.65 | 848.70M | 79.95M | -4.60M | 10.19M | -0.1787 |
TAK
Takeda Pharmaceutical Co Adr
|
16.46 | 52.57B | 29.85B | 776.90M | 4.35B | 0.2408 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.73 | 41.93B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.11 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
82.83 | 36.72B | 9.47B | 2.67B | 2.28B | 6.0218 |
UTHR
United Therapeutics Corp
|
564.94 | 24.16B | 3.18B | 1.33B | 1.04B | 27.90 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
ETON SEC FilingsEton Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan
MSN - MSN
(ETON) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Eton Pharmaceuticals (ETON) surges 19.8%: Is this an indication of further gains? - MSN
Eton Pharmaceuticals, Inc. (ETON) Q4 earnings lag estimates - MSN
Eton Pharmaceuticals (ETON) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eton Pharmaceuticals (ETON), Amgen (AMGN) and BrightSpring Health Services, Inc. (BTSG) - The Globe and Mail
Eton Scales New Highs On Sustained Growth Momentum - RTTNews
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - The Manila Times
Eton Pharmaceuticals sets May 14 earnings report, webcast at 4:30 p.m. ET - Stock Titan
Eton Pharmaceuticals (ETON) Surges 19.8%: Is This an Indication of Further Gains? - Yahoo Finance
How The Hemangeol Deal Is Rewriting The Story For Eton Pharmaceuticals (ETON) - Yahoo Finance
Eton Pharmaceuticals Touches New High Amid Relaunch of Hemangeol - Moomoo
Eton Pharmaceuticals (NASDAQ:ETON) Reaches New 12-Month HighTime to Buy? - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Trading 13.3% HigherWhat's Next? - MarketBeat
Eton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution - TipRanks
Eton Pharmaceuticals relaunches Hemangeol with specialty pharmacy By Investing.com - Investing.com South Africa
Eton Pharmaceuticals, Inc. (ETON) announced that its product Hemangeol® (propranolol) oral solution has been officially relaunched. - Bitget
Eton Pharmaceuticals relaunches Hemangeol with specialty pharmacy - Investing.com
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution - The Manila Times
HEMANGEOL relaunch with Eton Cares support at Eton (NASDAQ: ETON) - Stock Titan
Eton Pharmaceuticals Announces Exclusive Launch of HEMANGEOL Through Anovo Specialty Pharmacy to Enhance Patient Access and Support for Infantile Hemangioma Treatment - Quiver Quantitative
Only FDA-approved infantile hemangioma drug returns with $0 copay - Stock Titan
Does Eton Pharmaceuticals (ETON) have the potential to rally 49.25% as Wall Street analysts expect? - MSN
Eton Pharmaceuticals (ETON) soars 6.7%: Is further upside left in the stock? - MSN
Eton Pharma drops after CFO succession plan - MSN
Recent price trend in Eton Pharmaceuticals (ETON) is your friend, here's why - MSN
Eton Pharmaceuticals Initiates Clinical Study for ET-700 Zinc Acetate Extended-Release Formulation for Wilson Disease - Minichart
Eton Starts Pilot Trial of ET-700 for Wilson Disease - TipRanks
Eton Pharmaceuticals doses first patient in Wilson disease study By Investing.com - Investing.com Australia
Eton Pharmaceuticals doses first patient in Wilson disease study - Investing.com
Eton Pharmaceuticals Announces First Patient Dosed in Pilot Study for ET-700 in Wilson Disease Treatment - Quiver Quantitative
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700 - The Manila Times
Eton Pharmaceuticals Initiates Clinical Study For Product Candidate ET-700 - marketscreener.com
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Rating of "Hold" by Brokerages - MarketBeat
(ETON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Eton Pharmaceuticals (ETON) price target increased by 25.56% to 38.42 - MSN
Eton Pharmaceuticals (ETON) 2026 proxy outlines director votes and 2025 CEO pay - Stock Titan
Eton Pharmaceuticals (ETON) Appoints Judith M. Matthews as New CFO - Insider Monkey
10 Best NASDAQ Growth Stocks to Buy and Hold Forever - Insider Monkey
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.49%
1.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):